| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/20/2005 | CN1197604C Ointment for treating burns and scalds, sore, bone tuberculosis and wounds |
| 04/20/2005 | CN1197595C Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing |
| 04/20/2005 | CN1197591C Use of acellular short corynebacteria preparation in preparation of medicine for treating tuberculosis |
| 04/20/2005 | CN1197578C Pharmaceutical suspension comprising nevirapine hemihydrate |
| 04/20/2005 | CN1197576C Medicine for treating venereal wart and its preparation method |
| 04/20/2005 | CN1197571C Metronidazole preparation and its preparing method |
| 04/20/2005 | CN1197570C Application of ampelopsin in preparation of medicine for preventing and treating AIDS |
| 04/20/2005 | CN1197560C Medicine for preventing or treating AIDS, and preparation and application thereof |
| 04/20/2005 | CN1197552C Preparations for the application of anti-inflammatory agents |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881846 Antiproliferative agents |
| 04/19/2005 | US6881831 Treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units. |
| 04/19/2005 | US6881821 Hepatitis-C virus type 4, 5, and 6 |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881745 Pharmaceutical compositions for poorly soluble drugs |
| 04/19/2005 | US6881742 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881731 Enhancers for microbiological disinfection |
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/19/2005 | US6881564 Enzymatic peptide comprising modified asparaginic residues for treatment of tumors, infection, liver and autoimmune disorders |
| 04/19/2005 | US6881411 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 04/19/2005 | US6881410 Treatment of E. faecium infection |
| 04/19/2005 | US6881406 Administering an effective amount of a Chemokine receptor (CCR4) modulating agent, in a dose effective to modulate trafficking of systemic memmory T cells |
| 04/19/2005 | CA2315189C Integrin receptor antagonists |
| 04/19/2005 | CA2295035C Pharmaceutical formulations containing voriconazole |
| 04/19/2005 | CA2139507C Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 04/14/2005 | WO2005033338A1 Method of evaluating risk for viral infection |
| 04/14/2005 | WO2005033301A1 Cell activation method and cell production method and medicinal composition using the same |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005033129A1 Antibacterial amide macrocycles |
| 04/14/2005 | WO2005033114A1 Polycyclic macrolactones |
| 04/14/2005 | WO2005033108A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 04/14/2005 | WO2005033107A1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation |
| 04/14/2005 | WO2005033077A1 Sequence selective pyrrole and imidazole polyamide metallocomplexes |
| 04/14/2005 | WO2005032576A1 Therapeutic agent for hepatitis c |
| 04/14/2005 | WO2005032561A1 INVENTION RELATING TO FUNCTION OF HIV-Vpr |
| 04/14/2005 | WO2005032557A1 Mycocide composition |
| 04/14/2005 | WO2005032542A1 Neutralizing agent for cavitating toxin |
| 04/14/2005 | WO2005032532A1 Antimycotic composition |
| 04/14/2005 | WO2005032531A1 Antimycotic composition |
| 04/14/2005 | WO2005032530A1 Pharmaceutical composition for external application |
| 04/14/2005 | WO2005032529A1 Mycocide composition |
| 04/14/2005 | WO2005032522A1 Topical aerosol foams |
| 04/14/2005 | WO2005032462A2 Glucocerebroside treatment of disease |
| 04/14/2005 | WO2005021026A3 Methods for treating or ameliorating ghrelin-associated diseases and disorders |
| 04/14/2005 | WO2005005424B1 Aztreonam l-lysine and methods for the preparation thereof |
| 04/14/2005 | WO2004108746A3 11-12 bicyclic erythromycin derivatives |
| 04/14/2005 | WO2004096197A8 5-aza-7-deazapurine nucleosides for treating flaviviridae |
| 04/14/2005 | WO2004014295A3 Tiacumicin production |
| 04/14/2005 | WO2003086453A9 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003015712A3 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin |
| 04/14/2005 | WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2005 | WO2000051613A3 Upper hitch link |
| 04/14/2005 | US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor |
| 04/14/2005 | US20050080255 Reacting cefdinir with potassium compound; salt formation; crystallization from solvent |
| 04/14/2005 | US20050080240 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080122 Anti-viral compounds |
| 04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
| 04/14/2005 | US20050080107 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080050 Lipid analogs for treating viral infections |
| 04/14/2005 | US20050080045 topical administration; prevention of STDs preferably a viral disease other than HIV, e.g. HPV or genital herpes and especially acyclovir resistant genital herpes |
| 04/14/2005 | US20050080041 Method and composition for the treatment of adenoviral ocular infections |
| 04/14/2005 | US20050080034 Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080025 Macrolides |
| 04/14/2005 | US20050080005 Macrocyclic peptides active against the hepatitis C virus |
| 04/14/2005 | US20050080004 Including teicoplanin which shares many chemical and microbiological characteristics with vancomycin, but which possesses higher activity against many Gram-positive bacteria and is less nephrotoxic |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers |
| 04/14/2005 | US20050079168 Virulence genes proteins and their use |
| 04/14/2005 | US20050079153 Methods for enhancing immune functions in neonatal mammals by administration of IL-18 |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | DE10343365A1 Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation Pharmaceutical formulations of xanthates and inhibitors of viral nucleic acid replication |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540646A1 Antibacterial amide macrocycles |
| 04/14/2005 | CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 04/13/2005 | EP1522307A1 Dialyzed leukocyte extract for the treatment of infectious diseases in animals |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521839A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521779A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 04/13/2005 | EP1521765A1 Bafilomycin-like metabolite from a novel micromonospora species |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521754A2 Viral inhibitors |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521592A2 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| 04/13/2005 | EP1521587A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 04/13/2005 | EP1521581A1 Diarylmethylpiperazines as prophylactic or therapeutic agents for viral myocarditis |
| 04/13/2005 | EP1521571A1 Solid dispersion comprising two different polymer matrixes |